Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine

Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine

Background: Melanoma remains largely resistant to currently available chemotherapy, and new strategies have been proposed to flank standardized therapeutic protocols in an effort to improve efficacy. Such an approach requires good knowledge of the mechanisms involved in the resistance and survival o...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Ivan Vannini, Massimiliano Bonafe, Anna Tesei, Marco Rosetti, Francesco Fabbri, Gianluca Storci, Paola Ulivi, Giovanni Brigliadori, Dino Amadori, Wainer Zoli
Format:	Artykuł
Język:	English
Wydane:	Hindawi Limited 2007-01-01
Seria:	Cellular Oncology
Dostęp online:	http://dx.doi.org/10.1155/2007/540821

Podobne zapisy

Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
od: Vannini Ivan, i wsp.
Wydane: (2007-10-01)

<it>In vitro </it>and <it>in vivo </it>evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines
od: Zupi Gabriella, i wsp.
Wydane: (2005-02-01)

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
od: Ibrahim Toni, i wsp.
Wydane: (2012-11-01)

Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: A cytometric study
od: Lapalombella Rosa, i wsp.
Wydane: (2006-01-01)

Sensitivity of Zebrafish Embryogenesis to Risk of Fotemustine Exposure
od: Davide Di Paola, i wsp.
Wydane: (2022-03-01)

Cellular Basis of Antiproliferative and Antitumor Activity of the Novel Camptothecin Derivative, Gimatecan, in Bladder Carcinoma Models
od: Paola Ulivi, i wsp.
Wydane: (2005-02-01)

miRNAs as Non-Invasive Biomarkers for Lung Cancer Diagnosis
od: Paola Ulivi, i wsp.
Wydane: (2014-06-01)

Effects of fotemustine or dacarbasine on a melanoma cell line pretreated with therapeutic proton irradiation
od: Privitera Giuseppe, i wsp.
Wydane: (2009-04-01)

Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study
od: Raffaele Addeo, i wsp.
Wydane: (2019-06-01)

Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
od: Celina Bihan, i wsp.
Wydane: (2012-09-01)

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
od: Mirri Maria, i wsp.
Wydane: (2009-03-01)

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study
od: Ulivi Paola, i wsp.
Wydane: (2012-05-01)

Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin
od: Qia Xu, i wsp.
Wydane: (2022-06-01)

Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells
od: Mitrugno Valentina, i wsp.
Wydane: (2010-11-01)

Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy
od: Turci Livia, i wsp.
Wydane: (2011-06-01)

Multiple marker detection in peripheral blood for NSCLC diagnosis.
od: Paola Ulivi, i wsp.
Wydane: (2013-01-01)

High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study
od: Giudice Giuseppe, i wsp.
Wydane: (2010-11-01)

HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles
od: Sabrina De Carolis, i wsp.
Wydane: (2019-09-01)

Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function
od: Jingyao Dong, i wsp.
Wydane: (2022-05-01)

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
od: Haslehurst Alexandria M, i wsp.
Wydane: (2012-03-01)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
od: Molinari Chiara, i wsp.
Wydane: (2011-11-01)

Enhanced Cisplatin Cytotoxicity by RNA Interfering the Excision Repair Cross-complementing Gene 1 in Lung Cancer Cell A549/DDP
od: Yun GAO, i wsp.
Wydane: (2010-09-01)

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
od: Zoli Wainer, i wsp.
Wydane: (2008-10-01)

Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models.
od: Anna Tesei, i wsp.
Wydane: (2013-01-01)

TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer
od: Anna Tesei, i wsp.
Wydane: (2021-03-01)

Predictive Role of Telomerase Activity in the Clinical Outcome of Patients with Benign Lesions of the Uterine Cervix or CIN
od: Sara Bravaccini, i wsp.
Wydane: (2012-01-01)

Interfering lncRNA XIST inhibits the growth of salivary adenoid cystic carcinoma cells and improves cisplatin sensitivity by up-regulating miR-429
od: Zhang Xuan, Ma Licheng, Sun Longxiao, Zhang Lei
Wydane: (2022-07-01)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience
od: Maltoni Roberta, i wsp.
Wydane: (2006-03-01)

Slug flow
od: Griffith, P., i wsp.
Wydane: (2011)

Hinokitiol inhibits Aspergillus fumigatus by interfering with the cell membrane and cell wall
od: Fanyue Meng, i wsp.
Wydane: (2023-04-01)

Reciprocal expression of Slug and Snail in human oral cancer cells.
od: Ryosuke Nakamura, i wsp.
Wydane: (2018-01-01)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
od: Enrico Maffini, i wsp.
Wydane: (2022-11-01)

Slug Mediates MRP2 Expression in Non-Small Cell Lung Cancer Cells
od: Xieyi Zhang, i wsp.
Wydane: (2022-06-01)

Slug-expressing mouse prostate epithelial cells have increased stem cell potential
od: Zuzana Kahounová, i wsp.
Wydane: (2020-07-01)

The Suppression of Multidrug Resistance in Leukemic Cells by Short Interfering RNA
od: Fatemeh Nadali, i wsp.
Wydane: (2009-07-01)

Interfering with water
od: Clary, D
Wydane: (1999)

Interfering with transmission
od: Andreas Wack
Wydane: (2018-05-01)

Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State
od: Guo, Wenjun, i wsp.
Wydane: (2014)

KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma
od: Julia Ingruber, i wsp.
Wydane: (2021-03-01)

Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells
od: Jeannette Huaman, i wsp.
Wydane: (2019-06-01)